A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, ...
Hosted on MSN5h
Ozempic Could Help Curb AlcoholismThe research was led by Dr. Markku Lähteenvuo, of the University of Eastern Finland. Besides the finding that both ...
Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...
A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...
Semaglutide and liraglutide are associated with reduced AUD and SUD-related hospitalization risks, unlike other GLP-1 ...
GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart ...
Examples include dulaglutide, exenatide extended-release, liraglutide and semaglutide (injectable and oral). Short-acting RA: ...
About The Study: Among patients with alcohol use disorder (AUD) and comorbid obesity/type 2 diabetes, the use of semaglutide and liraglutide were associated with a substantially decreased risk of ...
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Weight loss drugs like Ozempic and Wegovy may provide strong relief from severe osteoarthritis knee pain, new research finds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback